APA (7th ed.) Citation

SH, S., K, B., LF, G., J, H., E, S., A, A., . . . TC, T. (1992). The relationship between paroxetine and the sparteine oxidation polymorphism. Clinical pharmacology and therapeutics, 51(3), 278. https://doi.org/10.1038/clpt.1992.23

Chicago Style (17th ed.) Citation

SH, Sindrup, et al. "The Relationship Between Paroxetine and the Sparteine Oxidation Polymorphism." Clinical Pharmacology and Therapeutics 51, no. 3 (1992): 278. https://doi.org/10.1038/clpt.1992.23.

MLA (9th ed.) Citation

SH, Sindrup, et al. "The Relationship Between Paroxetine and the Sparteine Oxidation Polymorphism." Clinical Pharmacology and Therapeutics, vol. 51, no. 3, 1992, p. 278, https://doi.org/10.1038/clpt.1992.23.